The global optogenetics market is anticipated to grow at a significant CAGR during the forecast period. The optogenetics method is used specifically for the study of neural circuits present in the brain. It combines genetics and optical techniques together to control the neural circuit in a living brain. Applications of optogenetics methods are very wide for understanding the dysfunctional and normal behavior of the living brain. Moreover, optogenetic techniques can also be used to study the underlying factors in various disorders such as depression, anxiety, epilepsy, Parkinson's disorders, and others.

Additionally, factors such as increasing incidences of depression, mood disorders, Parkinson’s disease, and other related disorders will also drive the optogenetics market as they have the potential application of optogenetics. However, the limited awareness of optogenetics in developing economies as compared to developed economies will present as a challenge for the optogenetics market growth.

Segmental Outlook 

The optogenetics market is segmented on the basis of the light type, technique, and application. Based on the light, the market is sub-segmented into lasers and LEDs. Based on the technique, the market is sub-segmented into channelrhodopsin, halorhodopsin, and archaerhodopsin. Based on the application, the market is sub-segmented into retinal disease treatment, neuroscience, behavioral tracking & pacing, and others.

Global Optogenetics Market Share by Light Type, 2018 (%)

LEDs Segment to Contribute a Significant Share

Based on the light type segment, LED sub segment is anticipated to hold a significant share in the optogenetics market. The growth of the segment is owing to the fact that LEDs are reliable, comparatively cheaper, easier to control, and smaller in size than other types of lights. The increasing optogenetics research based on LED is also significantly driving the LED segment of the optogenetics market. For instance, a team of researchers from Universities of Strathclyde and Utah has recently developed an LED optical array in 2019. The LED optical ray is capable of providing wide-area brain surface illumination along with illumination specific brains are. The current studies are only tested on mice as they have a small brain size and require less optic fiber. 

Regional Outlooks

The global optogenetics market is further segmented based on geography into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold the largest market share in the optogenetics during the forecast period. The well developed and technologically advanced healthcare research sector is anticipated to drive the optogenetics market in the region. Along with North America, Europe also has good potential for the growth of the optogenetics market in the region. The growth of the optogenetics market in Europe is associated with the increasing R&D activities associated with the various application of the optogenetics market.

Global optogenetics Market Growth by Region, 2019-2025

Asia-Pacific will Augment with the Fastest Growth Rate in the Optogenetics Market 

Asia-Pacific is anticipated to exhibit the fastest growth rate in the optogenetics market due to the growing healthcare sector researches across the region. India and China are the major economies in Asia-Pacific and the market of optogenetics will grow considerably in both regions owing to their advanced healthcare system and research facilities. Additionally, increasing research and application of genetic engineering in the regions is also fueling the optogenetics market.

Market Players Outlook

Some of the key players of the optogenetics market include HUBNER Group, Bruker Corp., Ready Lasers, Scientifica, Shanghai Laser & Optics Century Co. Ltd., Thorlabs Inc., and others. The market players are considerably contributing to the market growth by adopting various strategies including new product launch, merger, and acquisition, collaborations to stay competitive in the market. 

Recent Activities

• In April 2020, Gensight Biologics S.A announced the completion of a second planned safety review of the ongoing PIONEER Phase I/II clinical trial of GS030, by independent Data Safety Monitoring Board (DSMB). The company’s product combines gene therapy and optogenetics together for the treatment of Retinitis Pigmentosa (RP). The company’s product GS030 is based on an optogenetics technology platform developed by the company itself. The GS030 uses gene therapy to introduce a gene encoding for a light-sensitive protein into retinal ganglion cells by a single intravitreal injection, making them responsive to light and bypassing photoreceptors killed off by the disease. 
• In July 2019, researchers from RMIT (Royal Melbourne Institute of Technology) University using the inspiration from optogenetics developed a device that is capable of replicating the way brain stores and loses information. The application of optogenetics allows scientists to delve into the body's electrical system using light to manipulate neurons so that they can be turned on or off.
• In November 2018, Bruker Corp. Introduced a wide-field, multiphoton microscope called Ultima 2P plus that has an application in optogenetics. The laser is designed for large-animal imaging, and the system uniquely suited for advanced neuroscience inquiry into awake animals.

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global optogenetics market. Based on the availability of data, information related to products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.